FOXP3 and breast carcinoma: Cui et al. [52] found that targeting the reactivation of non-mutated alleles on the inactivated X chromosome (XCI) inhibited tumor growth while targeting inhibition of the XIST of XCI enhanced and prolonged the activation of FoxP3, providing a potential treatment for female breast cancer.